Dysregulated YAP1/Hippo pathway contributes to doxorubicin (ADM)-resistance in acute myeloid leukemia (AML).
Sign Up to like & getrecommendations! Published in 2022 at "Current pharmaceutical biotechnology"
DOI: 10.2174/1389201023666220617150346
Abstract: BACKGROUND Dysregulated Yes-associated protein 1 (YAP1) is closely associated with cancer progression and chemo-resistance. We aim to explore the role of YAP1/Hippo pathway in regulating doxorubicin (ADM)-resistance in acute myeloid leukemia (AML). METHODS In this… read more here.
Keywords: hippo pathway; adm resistance; aml; resistance ... See more keywords